Start building a more resolutive network
Book a demo and we'll show you the impact with your network's own numbers.
Version 2.10 · In force since November 19, 2026
TERAL website, platforms, applications and integrations
| Item | Information |
|---|---|
| Provider | TERAL S.A.S., Tax ID (NIT) 901.616.741-2 |
| Address | Cra 43F #10-38, Manila, El Poblado, Medellín, Antioquia, Colombia. |
| Contact | Operations: daniela@teral.com.co. Privacy: alan@teral.ai; alternate: teralai@teralmed.co. Contact phone: +57 300 467 8602. |
| Surfaces | teral.ai/es, web platform, mobile applications, administration and institutional integrations |
| Version | v2.10, text updated on November 9, 2026 |
TERAL S.A.S., Tax ID (NIT) 901.616.741-2, with its principal domicile in Medellín and address for notices at Cra 43F #10-38, Manila, El Poblado, Medellín, Antioquia, Colombia, develops technology for clinical communication, case management, consults, administration and artificial intelligence.
These Terms govern access to the website, registration, web and mobile applications, administrative modules, tests, pilots, support and integrations. The institutional agreement, service order, DPA, security annex, SLA and particular conditions supplement these Terms and prevail as to their specific subject matter. That precedence operates between the parties to the specific instrument and in accordance with the hierarchy agreed; it does not impose obligations on third parties nor reduce mandatory rights. Publication of these Terms does not by itself modify agreements already executed.
Contracting requires an affirmative and verifiable manifestation, through signature, an unchecked box or an electronic flow that allows these Terms to be consulted and retained before acceptance. Creating or activating an account does not replace that manifestation. TERAL will retain the text and version accepted, the identity or account, the date and the evidence of acceptance. Mere browsing does not imply contracting or express authorization for health data, marketing or non-necessary cookies.
Records of contractual acceptance, acknowledgment of the notice, processing authorization and cookie choice will be kept separately, with the minimum necessary identifier, date and time, channel, purpose, version of the text presented and decision. They will be kept with restricted access and the possibility of later consultation; they will not be reused for marketing, and no additional data unnecessary to evidence the action will be collected.
The Platform may be used by health professionals, specialists, administrators, institutional clients and other authorized persons according to the account and the agreement. Anyone acting on behalf of an organization represents that they have sufficient authority; anyone administering institutional users must assign, review and revoke permissions in a timely manner.
The user must have legal capacity and, where practicing a regulated profession, keep their credentials, authorizations and licenses current. TERAL's documentary verification is an access control and does not constitute certification, clinical endorsement or a guarantee of competence.
Except under a written agreement and express legal authorization, TERAL is not a healthcare provider, does not directly provide health or telemedicine services, does not establish a doctor-patient relationship, does not diagnose, does not prescribe and does not replace the professional's judgment or the obligations of the licensed entity. This delimitation does not exempt TERAL from its technological obligations nor alter the legal classification of the activities it actually carries out. Care services enabled through the Platform must identify the provider and comply with the applicable health regulations.
Opinions, responses, summaries, classifications and recommendations available on the Platform must be reviewed by the competent professional or institution. TERAL provides the technological means and the traceability, but does not direct the clinical autonomy of third parties.
Depending on the product, plan, country and agreement, TERAL may enable an informational website, web platform, mobile applications, administration modules, user management, upload and consultation of cases, consults, comments, generation of supporting documents, notifications, analytics, AI assistance, support and integrations.
The commercial description does not guarantee that every feature is active for every user. The enforceable scope, availability, limits, regions and service levels will be those indicated in the order, agreement or configuration in force. The foregoing does not exclude the objective conditions of the offer or advertising that are legally binding.
An integration may only be activated by an authorized user or client, through a written agreement and under a documented scope. The methods below are configured per project; describing them does not evidence that they are active for every client, nor does it authorize access to third-party systems.
Every integration requires its own agreement and technical annex defining fields, permissions, destinations and controls. An image may contain identifiers in its text or metadata; masking faces or tattoos does not guarantee anonymization. The technical availability of a connection or function does not imply that it is legally or contractually enabled.
Before capturing, uploading or allowing access to clinical information, whoever determines the purpose of the processing must have the applicable authorization or legal exception, inform the data subject, limit the data to what is necessary and retain the corresponding evidence. TERAL will meet the obligations of a Controller when it decides the purpose and of a Processor when it acts exclusively on behalf of and under the instructions of another Controller. A clinic's permission to access its premises or make records does not replace the data subject's authorization or care consent where they are required.
TERAL will be Controller for its own purposes of website, contact, account, credentials, billing, support and security. In clinical operations carried out exclusively on behalf of a professional or institution, it will act as Processor. If TERAL determines a clinical, auditing, research, training, evaluation or improvement purpose of its own, it will meet the obligations of a Controller for that purpose and must have the corresponding legal support before processing the data. Acceptance of these Terms does not replace express authorization for sensitive data or clinical informed consent. The allocation of roles depends on actual decisions and activities, not on the contractual label or on who engages the physician.
The party responsible for care must incorporate into the medical record the opinions or results that legally correspond, preserving their integrity, authorship, date, scope and context. TERAL does not become custodian of the medical record merely by hosting or technically transporting information. However, it must comply with the duties of security, integrity, availability and retention that correspond to it as provider or Processor.
Opinions, views and responses are issued by their authors under professional autonomy and on the basis of the information available. They do not guarantee an outcome and do not replace an in-person assessment where one is necessary. Their clinical scope depends on the service, the professional's competence and the rules applicable to the modality used. The professional must refrain from concluding where the information is insufficient, ambiguous or illegible, and must indicate whether the case requires priority or in-person care.
The Platform may record author, date, time, case, version, attachments and related events. That technological traceability is not equivalent to clinical validation by TERAL.
TERAL may offer search, classification, summarization, draft generation, consistency auditing, conversational assistance or information retrieval. Outputs may contain errors, omissions, bias, hallucinations or out-of-context references.
Text protection controls do not by themselves evidence equivalent protection of images, screenshots, metadata or retrieved sources. Each flow requires defining and verifying the appropriate prior measures and the review or suspension procedure if they prove insufficient. Sending data without a legal basis or without the necessary security measures is not authorized. A function may be presented as de-identified only once that outcome has been verified. Using AI or OCR does not by itself provide universal anonymization.
TERAL may classify, organize and cross-check information using rules and criteria defined for each service and generate observations, alerts or recommendations for human review. These functions may support the review of documentation, billing, procedures or medical prescriptions. Their outputs do not by themselves constitute a finding of fraud or a final decision on care, dispensing, coverage or payment. Recommendations are not binding. The competent person must review the output and may accept or disregard it according to their professional judgment and the applicable rules. The scope, the authorized data, the rules, their versions and the responsibilities will be established for each project.
Image analysis functions may produce false positives, false negatives or inconclusive results. The absence of alerts does not prove authenticity, absence of tampering or diagnostic validity. Synthetic demonstrations show the available workflow; they do not certify clinical effectiveness or replace the validation required for the contracted use. If a check could not be run or did not produce a valid conclusion, that status must be distinguished from a verified negative result.
Before using AI with clinical impact, the required technical and clinical validations, the information to be given to the patient in advance, human supervision and traceability must be documented. If the use requires health authorization or registration, it must be obtained before operating. TERAL and the provider will comply with the obligations that correspond to each; this text does not evidence licensing, INVIMA registration or clinical validation of the product.
Data processing is governed by the Privacy Policy and, for institutional relationships, by the DPA and the security annex. Where there is a conflict regarding instructions, data categories, sub-processors, incidents, return or deletion, the specific document valid for the flow will prevail, without reducing the data subject's legal rights.
Including an AI function, provider or data category in the general description of the Platform does not enable it for every client. Each activation will respect the documented instructions, scope and exclusions of the applicable agreement and DPA. Where a signed instrument initially excludes AI processing or requires a Change Order, that condition must be met before activation; it is not modified by publishing these Terms or a Privacy Policy.
Infrastructure and AI services may include Amazon Web Services —Comprehend and Bedrock with Claude models—, Google Cloud Vertex AI/Gemini and MongoDB Atlas, with processing in United States regions or in the locations of the specific service reported for the project. Teral Incorporated may engage these providers within the service delivery chain, under the applicable instructions and obligations. Optional analytics functions through Google Analytics/Firebase or PostHog require a valid choice under the Cookie Policy and must respect its rejection or withdrawal. Direct connections with other providers, including Anthropic or OpenAI, are not enabled merely because they are technically available. Material changes will be documented and reported in accordance with the applicable law and agreement.
Optional measurement of browsing and usage is governed by the Cookie Policy and the user's specific choice. Rejecting or withdrawing it does not prevent contracting or using functions independent of that measurement. Account, session or activity identifiers are not considered anonymous merely because names are replaced. Clinical data and case, chat or call identifiers will not be reused for general commercial analytics; any metric essential to the service will have a separate purpose, fields, permissions and retention.
In the event of an incident affecting the information or the contracted service, TERAL will adopt containment measures, preserve evidence and communicate without undue delay to the client or Controller the information available regarding scope, data affected, consequences and measures. It will not wait until the investigation is complete to issue the initial notice and will update it as appropriate. The specific deadlines in the DPA, the agreement and the law will be complied with; each party will handle the notifications to authorities or data subjects that correspond to it. Users may report events through the channels in section 24 or the agreed institutional channel, avoiding sending unnecessary clinical data.
Users must maintain confidentiality regarding patients, cases, credentials and other non-public information. If the Platform incorporates a name, professional registration number, electronic signature, digital signature or signature image, its use will be limited to the act actually issued by the professional. Copying, cropping, editing or reusing those elements outside their context without specific authorization is prohibited. A signature image does not by itself constitute a digital signature or sufficient proof of authorization for other acts. The applicable method must make it possible to evidence identity, approval, integrity and retention; these Terms do not grant a mandate to sign opinions or invoices on behalf of a professional.
Each party retains the rights to its pre-existing content. The user or client grants TERAL a limited, non-exclusive license, revocable upon termination of the purpose, to host, technically reproduce, transmit, transform and display the content solely to the extent necessary to provide the service, comply with instructions and apply security.
The license does not authorize TERAL to sell clinical information or to use personal data to train or fine-tune models. A different purpose of its own requires the corresponding assessment, information, legal basis and controls; merely informing the user does not extend this license. The Platform, trademarks, software, interfaces, documentation and developments of TERAL remain protected, except for rights expressly granted by agreement.
Support is provided Monday to Friday during the technical team's business hours. Response times by severity and other commitments on availability, RTO, RPO or credits are governed by the applicable institutional SLA; no general guarantee of response time or continuous support is published. The institutional support channels are those agreed with each client.
Changes that materially reduce a contracted feature will be handled in accordance with the agreement. TERAL may withdraw experimental or non-contracted features, giving notice where reasonable.
TERAL may suspend or limit access due to a security risk, order of an authority, request of the institutional administrator, contractual default, prohibited use or material breach. Where the risk allows, it will communicate the cause and offer a reasonable opportunity to cure. The measure will be proportionate, limited to what is necessary and reviewed when its cause ceases. The legal obligations of continuity, access to records, export and handling of data subject requests that apply will be preserved; suspension does not authorize deleting evidence or withholding clinical data as leverage for payment.
Retention is limited to the purpose of the service, lawful instructions and the applicable obligations. Availability or storage commitments do not by themselves set the retention period of the medical record or authorize indefinite retention. Well-founded deletions must cover active copies and personal data in derivatives subject to the request or instruction. Temporarily retained backups will remain restricted and outside ordinary use, for the justified and documented period for recovery or applicable obligations; the deletions and restrictions in force must be reapplied before restored data return to ordinary use. On termination of the service, the corresponding return, export, deletion or legal retention must be carried out, with a record of its scope. Analytics retention is determined separately.
Prices, taxes, billing, term, renewal, suspension for non-payment and other financial conditions will be those established in the proposal, service order or agreement. These Terms do not incorporate card processing, automatic renewal, refunds or charges not expressly confirmed for the applicable product or plan. Where consumer legislation applies, the warranties, withdrawal, reversal and returns that are legally available will be respected; particular conditions may not eliminate them.
TERAL will provide the service with reasonable diligence and in accordance with the contracted scope. It does not guarantee clinical, commercial or regulatory outcomes; absolute accuracy of third-party or AI content; the total absence of interruptions; or compatibility with undocumented systems.
In business relationships where it is legally permissible, each party will be liable for direct damages attributable to its proven breach, in accordance with the limits validly agreed. This section does not exclude liability that cannot legally be waived, the rights of consumers, patients or data subjects, nor does it cover willful misconduct or gross negligence. TERAL retains liability for its own technological and data protection breaches. The legal burden of proof is not reversed, nor is a prior court ruling required as a general condition for bringing a claim.
Each party will be liable for third-party claims to the extent that they arise causally from a demonstrated breach legally attributable to it. This includes, where applicable, unlawful uploading of data, prohibited use, the party's own professional decisions or TERAL's technological breaches; it does not automatically attribute every Platform claim to the user. Defense costs must be reasonable and evidenced. Timely notice will be given, participation in the defense will be allowed, and no payments chargeable to the other party will be agreed without its consent, except where legally required. Personal sanctions and liabilities that the law makes non-transferable are not transferred. The parties will cooperate in preserving evidence and mitigating damages.
The Platform is not an emergency service.
In the event of an emergency or risk to life, the user must use the care and emergency channels defined by their institution and by local regulations. They must not wait for a response from TERAL or base immediate care on a consult or an AI output.
These Terms are governed by the laws of the Republic of Colombia. The parties may seek a direct, good-faith resolution. If no valid mechanism has been agreed in a specific contract, the competent authorities will hear the matter in accordance with the law. Negotiation does not prevent seeking urgent measures or bringing actions, rights or claims before the competent authority; the legal admissibility requirements and the non-waivable rights of consumers, patients and data subjects are respected.
TERAL will publish identifiable versions and report material changes before applying them. It will obtain a new acceptance or authorization where appropriate, without inferring it from silence, mere browsing or a cookie choice. This edition 2.10, dated November 9, 2026, applies from its effective publication, without retroactive effect or unilateral modification of signed instruments. It does not limit mandatory rights applicable by territory or processing.
Operational contact and service claims: daniela@teral.com.co. Privacy: alan@teral.ai; alternate: teralai@teralmed.co. Contact phone: +57 300 467 8602. Address: Cra 43F #10-38, Manila, El Poblado, Medellín, Antioquia, Colombia. This edition 2.10, dated November 9, 2026, enters into force upon its publication on TERAL's website, the date of which will be shown next to the published text. It has no retroactive effect and does not supersede signed agreements by publication. Users subject to a previous version will receive the information and, where applicable, the acceptance process set out in section 23.
Book a demo and we'll show you the impact with your network's own numbers.